Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Romosozumab for Premenopausal Idiopathic Osteoporosis

NCT04800367 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT04800367
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04800367 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Romosozumab for Premenopausal Idiopathic Osteoporosis
Lead sponsor
Columbia University
Phase
Phase 2
Overall status
Active, not recruiting
Start date
March 12, 2021
Completion date
March 31, 2028
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

premenopausal idiopathic osteoporosis